Список проголосовавших за комментарий " Gapping up/down: OCLR +9%, NFLX +7%, CHKP +4% after earnings, TSLA +4% after upgraade at MS; RCII -15%, PLXS -2% after earnings, X -1.5% and ASML -1% after dg's<p><strong>Gapping up<br/> In reaction to strong earnings/guidance</strong>:</p><ul><li><strong><strong>OCLR</strong></strong> +8.6%, <strong><strong>NFLX</strong></strong> +6.5%, <strong><strong>CHKP</strong></strong> +4.3%, <strong><strong>MTG</strong></strong> +3.7%, <strong><strong>UNP</strong></strong> +2.9%, <strong><strong>TAL</strong></strong> +2.8%, <strong><strong>WTFC</strong></strong> +2.7%, <strong><strong>BK</strong></strong> +2.6%, <strong><strong>PTC</strong></strong> +2.4%, <strong><strong>KEY</strong></strong> +0.7%, <strong><strong>BBT</strong></strong> +0.6%</li></ul><p><strong>M&A news</strong>:</p><ul><li><strong><strong>CYTX</strong></strong> +14.5% (to acquire certain assets from Azaya Therapeutics; Cytori to issue $2 mln in common stock up front)</li><li><strong><strong>PIP</strong></strong> +4.4% (PharmAthene and privately-held Altimmune announce merger in an all-stock transaction)</li><li><strong><strong>NTNX</strong></strong> +2.4% (M&A speculation (Cisco for Nutanix) from the Street.com after HPE bought hyperconverged peer SimpliVity)</li><li><strong><strong>LQ</strong></strong> +1.7% (La Quinta Holdings says pursuing the separation of its businesses into two stand-alone publicly traded companies, which could involve spinning off our owned real estate assets as a separate company)</li></ul><p><strong>Select Rail names showing strength after Hunter Harrison steps down as Canadian Pacific CEO to 'pursue opportunities involving other Class 1 Railroads'</strong>:</p><ul><li><strong>CSX</strong> +16.8%, <strong>NSC</strong> +3.6%, <strong>UNP</strong> +2.9%, <strong>KSU</strong> +2.4%</li></ul><p><strong>Other news</strong>:</p><ul><li><strong><strong>SSH</strong></strong> +15.3% (continued strength), <strong>ABEO</strong> +13.7% (EMA has granted Orphan Drug Designation for its gene therapy program ABO-101 for children impacted by Sanfilippo syndrome type B)</li><li><strong>NVCR</strong> +10.1% (announces physicians at 500 cancer treatment centers in the U.S. have been certified to prescribe its Optune to newly diagnosed and recurrent glioblastoma patientsg)</li><li><strong>SYN</strong> +8.5% (confirms plans to initiate a Phase 2b/3 adaptive pivotal trial for <strong>SYN</strong>-010; anticipates initiating this trial by the end of 1Q17)</li><li><strong>GALT</strong> +6.9% (Richard Uihlein discloses 7.89% active stake)</li><li><strong>MNK</strong> +4.2% (modestly rebounding; confirms details regarding FTC / Questcor matter; says no impact on Mallinckrodt net sales and will host call tomorrow at 7:30am ET), <strong>TDOC</strong> +2.4% (prices 8.25 mln share common stock offering (6.65 mln by Teladoc and 1.6 mln by stockholders) at $16.75/share)</li><li><strong>PSO</strong> +2% (modestly rebounding following yesterday's sell off)</li><li><strong>BHP</strong> +1% (preliminary agreement with federal prosecutors on behalf of Samarco Mineracao SA)</li></ul><p><strong><strong>Analyst comments</strong>:</strong></p><ul><li><strong><strong>TSLA</strong></strong> +4% (upgraded to Overweight from Equal Weight at Morgan Stanley)</li><li><strong>MBLY</strong> +4% (upgraded to Buy from Neutral at Goldman)</li><li><strong>HPQ</strong> +1.5% (upgraded to Buy from Neutral at UBS)</li><li><strong>PNRA</strong> +1.3% (upgraded to Buy from Neutral at Goldman)</li><li><strong>SWN</strong> +1.3% (upgraded at UBS)</li></ul><p><strong>Gapping down<br/> In reaction to disappointing earnings/guidance</strong>:</p><ul><li><strong>RCII</strong> -15.6%, (Rent-A-Center sees Q4 EPS loss of ($0.30)-($0.20) vs $0.10 Capital IQ Consensus Estimate)</li><li><strong>PLXS</strong> -2.3%, <strong>EGBN</strong> -1.4%, <strong>CP</strong> -1.2%, (also Canadian Pacific announces that Keith Creel will become President and CEO of the company effective January 31, 2017 following E. Hunter Harrison's decision to retire)</li><li><strong>FUL</strong> -0.9%, <strong>SBNY</strong> -0.9%, <strong>SLM</strong> -0.8%</li></ul><p><strong>Other news</strong>:</p><ul><li><strong>AMDA</strong> -28.9% ( to offer and sell common stock and warrants in an underwritten public offering; size not disclosed)</li><li><strong>ZYNE</strong> -13.8% (commences common stock offering)</li><li><strong>VNOM</strong> -6.5% (Viper Energy Partners commences public offering of 7,000,000 common units representing limited partner interests; reports prelim Q4 operational results/acquisition update )</li><li><strong>AAN</strong> -5% (RCII sympathy)</li><li><strong>HTGC</strong> -3% (commences $150 mln offering of its Convertible Senior Notes due 2022)</li><li><strong>HRTX</strong> -1.6% (commenced underwritten public offering of $150 million of shares of its common stock)</li><li><strong>AA</strong> -1% (files for 36,311,767 share common stock offering by selling stockholders)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>GNC</strong> -4.8% (downgraded to Sell from Neutral at Goldman)</li><li><strong>SFM</strong> -3.5% (downgraded to Neutral from Buy at Goldman)</li><li><strong>AKS</strong> -2.8% (downgraded to Sell from Neutral at Citigroup)</li><li><strong>RCL</strong> -1.9% (downgraded to Sell from Neutral at Goldman)</li><li><strong>KATE</strong> -1.6% (downgraded to Neutral from Buy at BofA/Merrill)</li><li><strong>X</strong> -1.5% (downgraded to Neutral from Buy at Citigroup)</li><li><strong>ASML</strong> -1.2% (downgraded to Neutral from Buy at Citigroup)</li></ul>"